November 28, 2020

Volume X, Number 333

M. Elizabeth Bierman

M. Elizabeth Bierman represents US and international companies in US Food and Drug Administration (FDA) and state regulatory matters that impact the development, manufacturing, and marketing of their products. Beth has more 25 years of experience representing companies that produce a range of products regulated by the FDA, including medical devices, digital health products and mobile medical applications, tissue products, combination products, pharmaceuticals, medical foods, and infant formulas. She also provides guidance on related jurisdictional issues and regulatory pathway strategies.

Articles in the National Law Review database by M. Elizabeth Bierman

TRENDING LEGAL ANALYSIS

Upcoming Legal Education Events

Tuesday, December 8, 2020
Wednesday, December 9, 2020
Wednesday, December 9, 2020
Wednesday, December 9, 2020
Thursday, December 10, 2020
Thursday, December 10, 2020
Thursday, December 17, 2020